The Expanding Diversity of Mycobacterium tuberculosis Drug Targets-Reference-Cited by-同舟云学术

The Expanding Diversity of Mycobacterium tuberculosis Drug Targets

Published:2018-02-07 Issue:5 Volume:4 Page:696-714
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Wellington Samantha¹²³^ORCID,Hung Deborah T.¹²³^ORCID

Affiliation:

1. Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States

2. Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States

3. Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, Massachusetts 02114, United States

Funder

Pershing Square Foundation

Broad Institute Tuberculosis Donor Group

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.7b00255

Reference174 articles.

1. Advances in the development of new tuberculosis drugs and treatment regimens

2. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

3. The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets

4. Hit and lead criteria in drug discovery for infectious diseases of the developing world

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzohydroxamate and nitrobenzohydroxamate affect membrane order: Correlations between spectroscopic and molecular dynamics to approach tuberculosis;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-12

2. Imidazooxazine moiety as polyketide synthase 13 inhibitors targeting tuberculosis;Journal of King Saud University - Science;2024-07

3. Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery;Pharmaceutics;2024-05-28

4. Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis;Scientific Reports;2024-05-13

5. New thiazolyl-isoxazole derivatives as potential anti-infective agents: design, synthesis, in vitro and in silico antimicrobial efficacy;Journal of Biomolecular Structure and Dynamics;2024-01-23